TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates21-10-2024
21-10-2024
NPPA slaps 6.32 lakh penalty on Torrent Pharma for Drug Pricing Violation, shares in green
Torrent Pharmaceuticals stated that the order would not have any material financial impact on the company's operations18-10-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201518-10-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201515-10-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Post Quarterly Financial Result Conference call with investors / analyst14-10-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 ,inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on 30-Sep-24.10-10-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Closure of Trading Window
Intimation of Closure of Trading Window27-09-2024
Torrent Pharma Refutes Claims Of Its Vitamin D Supplement Failing Drug Quality Test
The sample of tablets that was collected for analysis by CDSCO was non-genuine and spurious, Torrent Pharma claimed.26-09-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Acquisition
Intimation for Incorporation of Wholly Owned Subsidiary (WOS)26-09-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release Attached.26-09-2024